Hidden breast cancer subtype revealed in gulf study
NCT ID NCT06125314
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This study looked back at medical records of over 500 women in Gulf countries with advanced breast cancer that was previously labeled as HER2-negative. Researchers re-tested old tumor samples to find out how many actually had a newer subtype called HER2-low. The goal was to better understand how common this subtype is and how it behaves, which could help doctors choose better treatments in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Kuwait City, Kuwait
-
Research Site
Doha, Qatar
-
Research Site
Mecca, Saudi Arabia, Saudi Arabia
-
Research Site
Riyadh, Saudi Arabia
-
Research Site
Abu Dhabi, United Arab Emirates
-
Research Site
Al Ain City, United Arab Emirates
-
Research Site
Dubai, United Arab Emirates
Conditions
Explore the condition pages connected to this study.